Editors: Atta-ur-Rahman , M. Iqbal Choudhary

Frontiers in Anti-Infective Drug Discovery

Volume 4

eBook: US $109 Special Offer (PDF + Printed Copy): US $185
Printed Copy: US $131
Library License: US $436
ISSN: 2451-9162 (Print)
ISSN: 1879-663X (Online)
ISBN: 978-1-68108-083-3 (Print)
ISBN: 978-1-68108-082-6 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810808261150401


This eBook series brings updated reviews to readers interested in advances in the development of anti-infective drug design and discovery. The scope of the eBook series covers a range of topics including rational drug design and drug discovery, medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships.

Frontiers in Anti-Infective Drug Discovery is a valuable resource for pharmaceutical scientists and post-graduate students seeking updated and critically important information for developing clinical trials and devising research plans in this field.

The fourth volume of this series features 5 chapters that cover the following topics:

  • - An overview of the incidence of neuraminadase resistance in influenza viruses in the Americas from 2004 to 2014
  • - Phenothiazines and derivative compounds for treating Trypanosoma cruzi infections
  • - New antibacterial drug targets such as polysaccharide deacetylases
  • - Improvements in aminoglycoside synthesis and biological activity (including RNA targeting)
  • - A review of new chemotherapeutic agents against common infections.

Indexed in: Book Citation Index, Science Edition, BIOSIS Previews, Scopus, EMBASE, EBSCO, Ulrich's Periodicals Directory.


Your Rating *